PBYI icon

Puma Biotechnology
PBYI

Overview Fund Activity

102 hedge funds and large institutions have $92.2M invested in Puma Biotechnology in 2021 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 38 increasing their positions, 34 reducing their positions, and 33 closing their positions.

Holders
102
Holders Change
-13
Holders Change %
-11.3%
% of All Funds
1.58%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
38
Reduced
34
Closed
33
Calls
$725K
Puts
$519K
Net Calls
+$206K
Net Calls Change
-$231K

Top Buyers

1
Goldman Sachs
1
Goldman Sachs
New York
$6.94M
2
EP
2
Eversept Partners
New York
$3.4M
3
D.E. Shaw & Co
3
D.E. Shaw & Co
New York
$2.24M
4
Acadian Asset Management
4
Acadian Asset Management
Massachusetts
$5.31M
5
Walleye Capital
5
Walleye Capital
New York
$1.23M

Top Sellers

1
FAM
1
Fred Alger Management
New York
$0
2
PAI
2
Palo Alto Investors
California
$0
3
GPP
3
Great Point Partners
Connecticut
$0
4
ACM
4
AIGH Capital Management
Maryland
$0
5
CCM
5
Camber Capital Management
Massachusetts
$6.23M
Name Holding Trade Value Shares
Change 		Shares
Change %
Public Employees Retirement Association of Colorado
126
Public Employees Retirement Association of Colorado
Colorado
– -$50K -7,106 Closed
Canada Life
127
Canada Life
Manitoba, Canada
– -$14K -2,002 Closed
OSAM
128
O'Shaughnessy Asset Management
Connecticut
– -$11K -1,560 Closed
PCM
129
Penserra Capital Management
California
– -$6K -930 Closed
Baillie Gifford & Co
130
Baillie Gifford & Co
United Kingdom
– -$2K -252 Closed
CS
131
Candriam SCA
Luxembourg
– -$502K – –
2 3 4 5
6